These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
21. Factors involved in absorption of organic mercuric compounds from rat small intestine: comparative study with mercuric chloride in situ. Endo T; Nakaya S; Kimura R Pharmacol Toxicol; 1989 Aug; 65(2):128-35. PubMed ID: 2813284 [TBL] [Abstract][Full Text] [Related]
22. The influence of pH on rectal absorption of sodium benzoate studied in man by rectal lumen perfusion. Böttger WM; Schoonen AJ; de Vries-Nijboer GW; Visser J; Meijer DF J Pharmacokinet Biopharm; 1990 Feb; 18(1):1-15. PubMed ID: 2329467 [TBL] [Abstract][Full Text] [Related]
23. Effect of tissue degeneration on drug transfer across in vitro rat intestine. Breschi C; Carelli V; Di Colo G; Nannipieri E Farmaco Sci; 1981 Mar; 36(3):166-80. PubMed ID: 7227503 [TBL] [Abstract][Full Text] [Related]
24. GI absorption of beta-lactam antibiotics. III: Kinetic evidence for in situ absorption of ionized species of monobasic penicillins and cefazolin from the rat small intestine and structure-absorption rate relationships. Tsuji A; Miyamoto E; Kubo O; Yamana T J Pharm Sci; 1979 Jul; 68(7):812-6. PubMed ID: 37320 [TBL] [Abstract][Full Text] [Related]
25. Partition and distribution coefficients of solutes and drugs in brush border membrane vesicles. Alcorn CJ; Simpson RJ; Leahy DE; Peters TJ Biochem Pharmacol; 1993 May; 45(9):1775-82. PubMed ID: 8494536 [TBL] [Abstract][Full Text] [Related]
26. Physicochemical and physiologic factors affecting the absorption of warfarin in man. O'Reilly RA; Nelson E; Levy G J Pharm Sci; 1966 Apr; 55(4):435-7. PubMed ID: 5960299 [No Abstract] [Full Text] [Related]
27. Absorption of 3-amino-1-methyl-5H-pyrido[4,3-b]indole, a mutagen-carcinogen present in tryptophan pyrolysate, from the gastro-intestinal tract in the rat. Kimura T; Nakayama T; Kurosaki Y; Suzuki Y; Arimoto S; Hayatsu H Jpn J Cancer Res; 1985 Apr; 76(4):272-7. PubMed ID: 3924701 [TBL] [Abstract][Full Text] [Related]
28. Ordered mesoporous silica induces pH-independent supersaturation of the basic low solubility compound itraconazole resulting in enhanced transepithelial transport. Mellaerts R; Mols R; Kayaert P; Annaert P; Van Humbeeck J; Van den Mooter G; Martens JA; Augustijns P Int J Pharm; 2008 Jun; 357(1-2):169-79. PubMed ID: 18325700 [TBL] [Abstract][Full Text] [Related]
29. Induction of liver cytochrome P450s by Danshen-Gegen formula is the leading cause for its pharmacokinetic interactions with warfarin. Zhang Z; Ge B; Zhou L; Lam TN; Zuo Z J Ethnopharmacol; 2014 Jul; 154(3):672-86. PubMed ID: 24832110 [TBL] [Abstract][Full Text] [Related]
30. Small intestinal absorption of bropirimine in rats and effect of bile salt on the absorption. Emori H; Yokohama S; Nishihata T J Pharm Pharmacol; 1995 Jun; 47(6):487-92. PubMed ID: 7674131 [TBL] [Abstract][Full Text] [Related]
31. Absorption sites of orally administered drugs in the small intestine. Murakami T Expert Opin Drug Discov; 2017 Dec; 12(12):1219-1232. PubMed ID: 28920464 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of the use of Classical Nucleation Theory for predicting intestinal crystalline precipitation of two weakly basic BSC class II drugs. Carlert S; Lennernäs H; Abrahamsson B Eur J Pharm Sci; 2014 Mar; 53():17-27. PubMed ID: 24345794 [TBL] [Abstract][Full Text] [Related]
33. Is the full potential of the biopharmaceutics classification system reached? Bergström CA; Andersson SB; Fagerberg JH; Ragnarsson G; Lindahl A Eur J Pharm Sci; 2014 Jun; 57():224-31. PubMed ID: 24075971 [TBL] [Abstract][Full Text] [Related]
34. Pulmonary absorption studies utilizing in situ rat lung model: designing dosage regimen for bronchial delivery of new drug entities. Chowhan ZT; Amaro AA J Pharm Sci; 1976 Nov; 65(11):1669-72. PubMed ID: 11336 [TBL] [Abstract][Full Text] [Related]
35. Biopharmaceutical studies on hydantoin derivatives. I. Physico-chemical properties of hydantoin derivatives and their intestinal absorption. Fujioka H; Tan T J Pharmacobiodyn; 1981 Oct; 4(10):759-70. PubMed ID: 7320829 [TBL] [Abstract][Full Text] [Related]
36. Determination of absorption characteristics of AG337, a novel thymidylate synthase inhibitor, using a perfused rat intestinal model. Hu M; Roland K; Ge L; Chen J; Li Y; Tyle P; Roy S J Pharm Sci; 1998 Jul; 87(7):886-90. PubMed ID: 9649359 [TBL] [Abstract][Full Text] [Related]
37. Terpene penetration enhancers in propylene glycol/water co-solvent systems: effectiveness and mechanism of action. Yamane MA; Williams AC; Barry BW J Pharm Pharmacol; 1995 Dec; 47(12A):978-89. PubMed ID: 8932680 [TBL] [Abstract][Full Text] [Related]
38. pH-Dependent Solubility and Dissolution Behavior of Carvedilol--Case Example of a Weakly Basic BCS Class II Drug. Hamed R; Awadallah A; Sunoqrot S; Tarawneh O; Nazzal S; AlBaraghthi T; Al Sayyad J; Abbas A AAPS PharmSciTech; 2016 Apr; 17(2):418-26. PubMed ID: 26202065 [TBL] [Abstract][Full Text] [Related]
39. Enhancing the intestinal absorption of poorly water-soluble weak-acidic compound by controlling local pH. Iwanaga K; Kato S; Miyazaki M; Kakemi M Drug Dev Ind Pharm; 2013 Dec; 39(12):1887-94. PubMed ID: 22443480 [TBL] [Abstract][Full Text] [Related]
40. [Study on intestinal absorption kinetics of syringopicroside in rats]. Cao Y; Li Y; Lv S; Wang Y Zhongguo Zhong Yao Za Zhi; 2012 May; 37(10):1487-90. PubMed ID: 22860467 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]